Maryanna E. Lanning - Concepedia

Author

Maryanna E. Lanning

University of Maryland, Baltimore

Also Known As

M. E. Lanning, Maryanna E. Lanning, Maryanna Lanning

Publications

533

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore U-M Rogel Cancer Center University of Maryland, College Park Cardiff University Bryn Mawr College

About

Maryanna E. Lanning is an author at University of Maryland, Baltimore specializing in pharmacology, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	179
2	Natural Sciences	4	4	207
3	Biochemistry	3	3	88
4	Engineering	2	2	72
5	Biomolecular Engineering	2	2	65

Maryanna E. Lanning

Publications

404

Citations

H-Index

Page 1

	Year	Citations
BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536 Lijia Chen, Jeremy L. Yap, Makoto Yoshioka, ACS Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryFocused LibraryPharmaceutical ChemistryBrd4 Structure–activity Relationships	2015	89
Perturbation of the c-Myc–Max Protein–Protein Interaction via Synthetic α-Helix Mimetics Kwan‐Young Jung, Huabo Wang, Peter Teriete, Journal of Medicinal Chemistry	2015	88
Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein Maryanna E. Lanning, Wenbo Yu, Jeremy L. Yap, European Journal of Medicinal Chemistry N-substituted 1-Hydroxy-4-sulfamoyl-2-naphthoatesCombinatorial ChemistryMedicinal ChemistryBiochemistryNatural Sciences	2016	46
Amphipathic α-Helix Mimetics Based on a 1,2-Diphenylacetylene Scaffold Kwan‐Young Jung, Kenno Vanommeslaeghe, Maryanna E. Lanning, Organic Letters Amphipathic α-Helix MimeticsEngineeringSupramolecular AssemblyNatural SciencesAmphipathic α-Helices	2013	44
Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling Kwan‐Young Jung, Ramin Samadani, Jay Chauhan, Organic & Biomolecular Chemistry Molecular DockingMedicinal ChemistryPharmaceutical ChemistrySignaling PathwayMedicine	2013	30
Structural Re‐engineering of the α‐Helix Mimetic JY‐1‐106 into Small Molecules: Disruption of the Mcl‐1–Bak‐BH3 Protein–Protein Interaction with 2,6‐Di‐Substituted Nicotinates Brandon Drennen, Jacob A. Scheenstra, Jeremy L. Yap, ChemMedChem	2016	28
Chromatography-Free Entry to Substituted Salicylonitriles: Mitsunobu-Triggered Domino Reactions of Salicylaldoximes E. E. Whiting, Maryanna E. Lanning, Jacob A. Scheenstra, The Journal of Organic Chemistry Combinatorial ChemistryMedicinal ChemistryBiosynthesisBioorganic ChemistryEngineering	2014	28
Azodicarbonyl dimorpholide (ADDM): an effective, versatile, and water-soluble Mitsunobu reagent Maryanna E. Lanning, Steven Fletcher Tetrahedron Letters PharmacologyAzodicarbonyl DimorpholidePharmaceutical ChemistryBiomolecular Engineering	2013	21
Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold Maryanna E. Lanning, Paul T. Wilder, Hala Bailey, Organic & Biomolecular Chemistry	2015	16
Rationally Designed Polypharmacology: α‐Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl‐1 and HDM2 Ivie L. Conlon, Brandon Drennen, Maryanna E. Lanning, ChemMedChem Chemoprevention StrategyApoptosisCell DeathCancer BiologyTumor Biology	2020	14

Page 1